These data together showed JM#21 induced antagonism toward CD19-mediated migration and combinatorial efficacy in ADCC for other WM and DLBCL cells, namely, MWCL-1 and OCI-Ly3 (Figure 4E,F and Figure 5C). Here, CD19 is linked to diffuse large B-cell lymphoma.